Details for Patent: RE44733

Which drugs does patent RE44733 protect, and when does it expire?

Patent RE44733 protects BRIDION and is included in one NDA.

This patent has forty-two patent family members in thirty countries.

Summary for Patent: RE44733

Title:	6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
Abstract:	Disclosed is a 6-mercapto-cyclodextrin derivative having general formula (I) wherein m is 0-7 and n is 1-8 and m+n=7 or 8; R is (C.sub.1-6)alkylene, optionally substituated with 1-3 OH groups, or (CH.sub.2).sub.o-phenylene-(CH.sub.2).sub.p--; o and p are independently 0-4; X is COOH, CONHR.sub.1, NHCOR.sub.2, SO.sub.2OH, PO(OH).sub.2, O(CH.sub.2--CH.sub.2--O).sub.q--H, OH or tetrazol-5-yl; R.sub.1 is H or (C.sub.1-3)alkyl; R.sub.2 is carboxyphenyl; q is 1-3; or pharmaceutically acceptable salts thereof. The 6-mercaptocyclodextrin derivative is highly suitable for use in the reversal of drug-induced neuromuscular block. ##STR00001##
Inventor(s):	Zhang; Mingiang (Montreal, CA), Palin; Ronald (Banton, GB), Bennett; Jonathan (Edinburgh, GB)
Assignee:	Merck Sharp & Dohme B.V. (Haarlem, NL)
Application Number:	13/432,742
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE44733
Patent Claim Types: see list of patent claims	Compound; Composition; Device; Use;

Drugs Protected by US Patent RE44733

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Msd Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015	AP	RX	Yes	No			Y	Y		REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK
Msd Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-001	Dec 15, 2015	AP	RX	Yes	Yes			Y	Y		REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK

Foreign Priority and PCT Information for Patent: RE44733

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	99309558	Nov 29, 1999

PCT Information
PCT Filed	November 23, 2000	PCT Application Number:	PCT/EP00/11789
PCT Publication Date:	June 07, 2001	PCT Publication Number:	WO01/40316

International Family Members for US Patent RE44733

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	026605
Austria	288450
Australia	5438001
Australia	776536
Brazil	0015947
Canada	2390463